Table 2.
Summary of Survey Responses Sorted by Clinical Service†
| Cardiology | Psychiatry | Pain | Infectious Diseases | Oncology | Transplant | Primary Care | Neurology | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PharmD (n=9) (%) | MD (n=8) (%) | PharmD (n=5) (%) | MD (n=9) (%) | PharmD (n=9) (%) | MD (n=11) (%) | PharmD (n=12) (%) | MD (n=5) (%) | PharmD (n=7) (%) | MD (n=9) (%) | PharmD (n=16) (%) | MD (n=11) (%) | PharmD (n=12) (%) | MD (n=16) (%) | PharmD (n=7) (%) | MD (n=4) (%) | |
| Currently using PG testing in practice | 3 (37) | 0 (0) | 2 (40) | 2 (22) | 3 (33) | 3 (27) | 6 (50) | 4 (80) | 2 (29) | 7 (78) | 7 (44) | 3 (27) | 4 (33) | 3 (19) | 1 (17) | 1 (25) |
| Interest in starting PG testing in practice | 5 (62) | 8 (100) | 3 (60) | 7 (78) | 6 (67) | 8 (73) | 6 (50) | 1 (20) | 5 (71) | 2 (22) | 9 (56) | 8 (73) | 8 (67) | 13 (81) | 5 (83) | 3 (75) |
| Observational studies sufficient evidence for PG testing | 8 (89) | 4 (50) | 4 (80) | 3 (33) | 4 (44) | 9 (82) | 8 (67) | 4 (80) | 4 (57) | 9 (100) | 13 (81) | 7 (64) | 10 (83) | 9 (56) | 7 (100) | 3 (75) |
†
All the pharmacists whom responded to the survey selected more than one clinical specialty in the survey.
PG = pharmacogenetics.